Study finds payments to Medicare Advantage brokers potentially reached $10 billion annually
Peer-Reviewed Publication
Updates every hour. Last Updated: 16-Jun-2026 10:15 ET (16-Jun-2026 14:15 GMT/UTC)
The analysis conducted by the research team at Brown’s Center for Advancing Health Policy through Research offers a rare behind-the-scenes look at this market, drawing on data obtained through a Freedom of Information Act request. The study found that broker involvement is both common and growing. In 2014, 36% of first-time Medicare Advantage enrollees used a broker, a figure that rose to 44% by 2022.
UCLA Health researchers have identified a potential drug target for treating Fragile X syndrome, the most common genetic cause of intellectual disability and autism that affects roughly 1 in 2,000 boys.UCLA Health researchers have identified a potential drug target for treating Fragile X syndrome, the most common genetic cause of intellectual disability and autism that affects roughly 1 in 2,000 boys.